MYC-dependent regulation and prognostic role of CIP2A in gastric cancer A Khanna, C Böckelman, A Hemmes, MR Junttila, JP Wiksten, M Lundin, ... Journal of the National Cancer Institute 101 (11), 793-805, 2009 | 266 | 2009 |
Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target A Khanna, JE Pimanda, J Westermarck Cancer research 73 (22), 6548-6553, 2013 | 210 | 2013 |
Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1 A Laine, H Sihto, C Come, MT Rosenfeldt, A Zwolinska, M Niemelä, ... Cancer discovery 3 (2), 182-197, 2013 | 156 | 2013 |
DNA damage in cancer therapeutics: a boon or a curse? A Khanna Cancer research 75 (11), 2133-2138, 2015 | 143 | 2015 |
Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers A Khanna, JE Pimanda International journal of cancer 138 (3), 525-532, 2016 | 103 | 2016 |
ETS1 mediates MEK1/2-dependent overexpression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in human cancer cells A Khanna, J Okkeri, T Bilgen, T Tiirikka, M Vihinen, T Visakorpi, ... PLoS One 6 (3), e17979, 2011 | 88 | 2011 |
Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation DP Mathiasen, C Egebjerg, SH Andersen, B Rafn, P Puustinen, A Khanna, ... Oncogene 31 (3), 390-401, 2011 | 59 | 2011 |
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells A Khanna, O Kauko, C Böckelman, A Laine, I Schreck, JI Partanen, ... Cancer research 73 (22), 6757-6769, 2013 | 54 | 2013 |
CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations A Khanna, JK Rane, KK Kivinummi, A Urbanucci, MA Helenius, ... Oncotarget 6 (23), 19661, 2015 | 32 | 2015 |
Constitutive CHK1 expression drives a pSTAT3–CIP2A circuit that promotes glioblastoma cell survival and growth A Khanna, JAI Thoms, BW Stringer, SA Chung, KS Ensbey, TR Jue, ... Molecular Cancer Research 18 (5), 709-722, 2020 | 23 | 2020 |
Assessment of the potential of pathological stains in human prostate cancer A KhAnnA, RA PAtil, AA DeshmuKh Journal of Clinical and Diagnostic Research: JCDR 8 (1), 124, 2014 | 13 | 2014 |
SMAD1 and SMAD5 Expression Is Coordinately Regulated by FLI1 and GATA2 during Endothelial Development. Marks-Bluth J, Khanna A, Chandrakanthan V, Thoms J, Bee T, Eich C, Kang YC ... Mol Cell Biol. 35 (12), 2165-72, 2015 | 12 | 2015 |
Regulation of Cancerous inhibitor of PP2A (CIP2A) by small molecule inhibitor for c-Jun NH 2-Terminal Kinases (JNKs), SP600125, in Human … A Khanna F1000Research 2, 174, 2013 | 4 | 2013 |
859 Constitutive DNA-damage signaling promotes cancer cell proliferation through Chk1-CIP2A pathway A Khanna, C Böckelman, A Laine, A Ristimäki, T Visakorpi, ... Ejc Supplements 8 (5), 217-217, 2010 | 4 | 2010 |
Strategies and vectors for gene therapy: Its prospective therapeutic attributes against restenosis A Khanna Journal of Clinical and Diagnostic Research 2 (3), 871-878, 2008 | 2 | 2008 |
Atlas of Genetics and Cytogenetics in Oncology and Haematology P Sharma, R Sharma | 2 | |
Keeping glioblastoma (GBM) in check by targeting the CHK1-STAT3-CIP2A axis A Khanna, B Stringer, B Day, K Ensbey, H Shen, A Boyd, K McDonald, ... Cancer Research 74 (19_Supplement), 1600-1600, 2014 | 1 | 2014 |
6650 Myc-dependent regulation and prgonostic role of Myc stabilizing protein, CIP2A, in human gastric cancer A Khanna, C Böckelman, J Westermarck, A Ristimäki EJC Supplements 2 (7), 403, 2009 | 1 | 2009 |
P3. 02-054 Prognostic Implications of ROS1 Positivity in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Published Literature A Khanna, S Ryan, J Youssef, A Mahmood Journal of Thoracic Oncology 12 (11), S2257, 2017 | | 2017 |
P2. 06-046 Shaping and Optimization of the Non-Small Cell Lung Cancer (NSCLC) Diagnostic Landscape in Australia and New Zealand (ANZ): Topic: LAB, Other A Khanna, M Alam Journal of Thoracic Oncology 12 (1), S1101, 2017 | | 2017 |